MedTrace Logo

Tissue Microarrays (TMAs) Construction in Lung Cancer Samples

NCT03136523 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 324

Last updated 2019-03-14

No results posted yet for this study

Summary

Construction of a large cohort of lung cancer patients to evaluate the Prognostic and Predictive Significance of the molecular biomarkers Epidermal growth factor receptor (EGFR), KRAS, Anaplastic lymphoma kinase (EML4-ALK), Programmed Death-Ligand 1 (PD-L1) protein and Microsatellite Instability (MSI) in lung cancer: A tissue microarray-based study of 500 cases.

Conditions

Sponsors & Collaborators

  • Kostas N.Syrigos

    lead OTHER

Principal Investigators

  • Konstantinos N Syrigos, MD,PhD · Non-Governmental, Non-Profit Organization

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2017-03-31
Completion
2018-09-28

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03136523 on ClinicalTrials.gov